Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc.verified

SNOA

Price:

$2.68

Market Cap:

$3.59M

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-01-25

Stock Exchange

NASDAQ

Ticker

SNOA

The Enterprise Value as of December 2024 (TTM) for Sonoma Pharmaceuticals, Inc. (SNOA) is -245024.00

According to Sonoma Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -245024.00. This represents a change of -208.41% compared to the average of 226.01K of the last 4 quarters.

Sonoma Pharmaceuticals, Inc. (SNOA) Historical Enterprise Value (quarterly & annually)

How has SNOA Enterprise Value performed in the past?

The mean historical Enterprise Value of Sonoma Pharmaceuticals, Inc. over the last ten years is 5.74M. The current -245024.00 Enterprise Value has changed -527.24% with respect to the historical average. Over the past ten years (40 quarters), SNOA's Enterprise Value was at its highest in in the June 2017 quarter at 16.31M. The Enterprise Value was at its lowest in in the September 2024 quarter at -659620.00.

Quarterly (TTM)
Annual

Average

5.74M

Median

4.82M

Minimum

-1129230.00

Maximum

13.29M

Sonoma Pharmaceuticals, Inc. (SNOA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sonoma Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 304.35%

Maximum Annual Enterprise Value = 13.29M

Minimum Annual Increase = -428.99%

Minimum Annual Enterprise Value = -1129230.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-1129230.00-428.99%
2023343.24K-92.55%
20224.61M-65.30%
202113.29M164.42%
20205.02M13.25%
20194.44M-37.92%
20187.15M-46.00%
201713.23M58.72%
20168.34M304.35%
20152.06M-90.00%

Sonoma Pharmaceuticals, Inc. (SNOA) Average Enterprise Value

How has SNOA Enterprise Value performed in the past?

The current Enterprise Value of Sonoma Pharmaceuticals, Inc. (SNOA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.27M

5-year avg

4.43M

10-year avg

5.74M

Sonoma Pharmaceuticals, Inc. (SNOA) Enterprise Value vs. Peers

How is SNOA’s Enterprise Value compared to its peers?

Sonoma Pharmaceuticals, Inc.’s Enterprise Value is less than China Pharma Holdings, Inc. (6.76M), greater than Universe Pharmaceuticals INC (-1026741.00), less than Acorda Therapeutics, Inc. (187.38M), greater than Akanda Corp. (-3317592.00), less than Petros Pharmaceuticals, Inc. (6.20M), greater than Sunshine Biopharma, Inc. (-5651124.00), greater than Guardion Health Sciences, Inc. (-10475955.00), less than Alpha Teknova, Inc. (433.84M), less than Cannara Biotech Inc. (106.52M), less than MC Endeavors, Inc. (607.62K), less than Unrivaled Brands, Inc. (42.89M), less than GelStat Corporation (775.53K), less than Shionogi & Co., Ltd. (1.57T), less than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-8217730.00), less than Shuttle Pharmaceuticals Holdings, Inc. (3.03M), less than Lifecore Biomedical, Inc. (390.24M), less than Mallinckrodt plc (2.67B), less than Journey Medical Corporation (92.41M),

Build a custom stock screener for Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonoma Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonoma Pharmaceuticals, Inc. (SNOA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonoma Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sonoma Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?

What is the 3-year average Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?

What is the 5-year average Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA)?

How does the current Enterprise Value for Sonoma Pharmaceuticals, Inc. (SNOA) compare to its historical average?